162 related articles for article (PubMed ID: 16739311)
1. SMAD4/DPC4 expression and prognosis in human colorectal cancer.
Isaksson-Mettävainio M; Palmqvist R; Forssell J; Stenling R; Oberg A
Anticancer Res; 2006; 26(1B):507-10. PubMed ID: 16739311
[TBL] [Abstract][Full Text] [Related]
2. Expression of Smad4 and TGF-beta2 in colorectal carcinoma.
Kouvidou Ch; Latoufis C; Lianou E; Kouvatseas G; Kakouri E; Anagnostakis D; Vrettou-Aravani V; Betsi E; Karatapanis S
Anticancer Res; 2006; 26(4B):2901-7. PubMed ID: 16886611
[TBL] [Abstract][Full Text] [Related]
3. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
[TBL] [Abstract][Full Text] [Related]
4. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
[TBL] [Abstract][Full Text] [Related]
5. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
[TBL] [Abstract][Full Text] [Related]
6. SMAD4 as a prognostic marker in colorectal cancer.
Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
[TBL] [Abstract][Full Text] [Related]
7. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
[TBL] [Abstract][Full Text] [Related]
8. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.
Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
Hum Pathol; 2005 Nov; 36(11):1204-9. PubMed ID: 16260274
[TBL] [Abstract][Full Text] [Related]
9. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer.
Kodach LL; Bleuming SA; Musler AR; Peppelenbosch MP; Hommes DW; van den Brink GR; van Noesel CJ; Offerhaus GJ; Hardwick JC
Cancer; 2008 Jan; 112(2):300-6. PubMed ID: 18008360
[TBL] [Abstract][Full Text] [Related]
10. Strong Smad4 expression correlates with poor prognosis after surgery in patients with hepatocellular carcinoma.
Hiwatashi K; Ueno S; Sakoda M; Kubo F; Tateno T; Kurahara H; Mataki Y; Maemura K; Ishigami S; Shinchi H; Natsugoe S
Ann Surg Oncol; 2009 Nov; 16(11):3176-82. PubMed ID: 19626374
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.
Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H
Br J Cancer; 2006 Dec; 95(11):1562-7. PubMed ID: 17088901
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
13. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer.
Lim SC; Lee TB; Choi CH; Ryu SY; Min YD; Kim KJ
J Surg Oncol; 2008 Jan; 97(1):51-6. PubMed ID: 17929263
[TBL] [Abstract][Full Text] [Related]
15. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer].
Tong XD; Liu HX; Zhao HR; Xu SG; Li Y; Han LB; Zhang L
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):741-5. PubMed ID: 17366784
[TBL] [Abstract][Full Text] [Related]
16. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
[TBL] [Abstract][Full Text] [Related]
17. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression.
Wang LH; Kim SH; Lee JH; Choi YL; Kim YC; Park TS; Hong YC; Wu CF; Shin YK
Clin Cancer Res; 2007 Jan; 13(1):102-10. PubMed ID: 17200344
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes.
Baker K; Chong G; Foulkes WD; Jass JR
Histopathology; 2006 Oct; 49(4):371-80. PubMed ID: 16978200
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
